NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Invion Limited (F: 7C8)
7C8 Technical Analysis
1
As on 23rd Dec 2024 7C8 STOCK Price closed @ 0.17 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
7C8STOCK Price
Open | 0.14 | Change | Price | % |
High | 0.17 | 1 Day | N/A | N/A |
Low | 0.14 | 1 Week | 0.00 | 0.00 |
Close | 0.17 | 1 Month | 0.00 | 0.00 |
Volume | 1000 | 1 Year | 0.00 | 0.00 |
52 Week High 0.00 | 52 Week Low 0.00 |
F Germany Most Active Stocks
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
ENB | 47.60 | -0.92% |
TEF | 3.84 | -0.52% |
TEF | 3.84 | -0.52% |
WHL | 5150.00 | -0.44% |
WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
7C8 Daily Charts |
7C8 Intraday Charts |
Whats New @ Bazaartrend |
7C8 Free Analysis |
|
7C8 Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
7C8 Forecast December 2024
4th UP Forecast | 0 |
3rd UP Forecast | 0 |
2nd UP Forecast | 0 |
1st UP Forecast | 0 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | 0 |
4th DOWN Forecast | 0 |
7C8 Weekly Forecast
4th UP Forecast | 0.00 |
3rd UP Forecast | 0.00 |
2nd UP Forecast | 0.00 |
1st UP Forecast | 0.00 |
1st DOWN Forecast | 0.00 |
2nd DOWN Forecast | 0.00 |
3rd DOWN Forecast | 0.00 |
4th DOWN Forecast | 0.00 |
7C8 Forecast2024
4th UP Forecast | 0 |
3rd UP Forecast | 0 |
2nd UP Forecast | 0 |
1st UP Forecast | 0 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | 0 |
4th DOWN Forecast | 0 |
Invion Limited ( F Germany Symbol : 7C8 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
7C8 Other Details
Segment | EQ | |
Market Capital | 362918496.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
7C8 Address
7C8 Latest News
7C8 Business Profile
Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia. Address: 722 High Street, Melbourne, VIC, Australia, 3102
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service